Heim4142 • TPE
add
Adimmune Corp
Við síðustu lokun
17,35 NT$
Árabil
15,90 NT$ - 22,60 NT$
Markaðsvirði
7,45 ma. TWD
Meðalmagn
2,46 m.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
TPE
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (TWD) | sep. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 475,32 m. | -46,49% |
Rekstrarkostnaður | 146,27 m. | -14,74% |
Nettótekjur | -18,26 m. | -106,93% |
Hagnaðarhlutfall | -3,84 | -112,96% |
Hagnaður á hvern hlut | — | — |
EBITDA | -19,68 m. | -106,24% |
Virkt skatthlutfall | — | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (TWD) | sep. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 1,79 ma. | -3,29% |
Heildareignir | 8,38 ma. | -2,80% |
Heildarskuldir | 3,53 ma. | 18,40% |
Eigið fé alls | 4,85 ma. | — |
Útistandandi hlutabréf | 421,51 m. | — |
Eiginfjárgengi | 1,55 | — |
Arðsemi eigna | -1,86% | — |
Ávöxtun eigin fjár | -1,94% | — |
Peningaflæði
Breyting á handbæru fé
| (TWD) | sep. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | -18,26 m. | -106,93% |
Handbært fé frá rekstri | -355,08 m. | -17,80% |
Reiðufé frá fjárfestingum | -173,61 m. | -102,13% |
Reiðufé frá fjármögnun | 403,21 m. | 5.593,35% |
Breyting á handbæru fé | -117,89 m. | 70,35% |
Frjálst peningaflæði | -460,83 m. | -29,17% |
Um
Adimmune Corporation is a Taiwanese biopharmaceutical company headquartered in Taichung. Originally founded in 1965 as Taiwan’s first vaccine laboratory, it later evolved into a modern vaccine manufacturer and contract development and manufacturing organization. The company is notable for being the only influenza vaccine manufacturer in Asia certified by both the European Union Good Manufacturing Practice and the U.S. Food and Drug Administration, and the*only human vaccine manufacturer in Taiwan operating under PIC/S GMP standards. Wikipedia
Stofnsett
1965
Vefsvæði
Starfsfólk
564
